These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12975689)

  • 21. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.
    Mason BJ; Lehert P
    Alcohol Clin Exp Res; 2012 Mar; 36(3):497-508. PubMed ID: 21895717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
    Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
    J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
    Kranzler HR; Gage A
    Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
    Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
    J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acamprosate. Pharmacoeconomic implications of therapy.
    Foster RH; McClellan KJ
    Pharmacoeconomics; 1999 Dec; 16(6):743-55. PubMed ID: 10724798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
    Kampman KM; Dackis C; Pettinati HM; Lynch KG; Sparkman T; O'Brien CP
    Addict Behav; 2011 Mar; 36(3):217-21. PubMed ID: 21112155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
    Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
    Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.
    Gueorguieva R; Wu R; Tsai WM; O'Connor PG; Fucito L; Zhang H; O'Malley SS
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1586-99. PubMed ID: 26141511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate.
    Zimmerman U; Spring K; Koller G; Holsboer F; Soyka M
    Pharmacopsychiatry; 2004 May; 37(3):98-102. PubMed ID: 15179967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
    Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
    Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.
    Tolliver BK; Desantis SM; Brown DG; Prisciandaro JJ; Brady KT
    Bipolar Disord; 2012 Feb; 14(1):54-63. PubMed ID: 22329472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
    Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
    Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.